Form D — Crossbow Therapeutics, Inc.
0000905148-25-003444 · filed 2025-09-30
Offering
- Industry
- Biotechnology
- Exemptions
- 06b
- Total offering
- $80,000,000
- Total sold
- $30,250,000
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- Crossbow Therapeutics, Inc.
- CIK
- 1972912
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2021
- Address
- 1030 Massachusetts Ave, Suite 210
Cambridge, MA 02138 - Phone
- 860-501-1600
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Briggs Morrison · Executive OfficerCambridge, MA Find on LinkedIn ↗
-
Todd Foley · DirectorCambridge, MA Find on LinkedIn ↗
-
Alexandra Cantley · DirectorCambridge, MA Find on LinkedIn ↗
-
Irena Melnikova · DirectorCambridge, MA Find on LinkedIn ↗
-
Charles Baum · DirectorCambridge, MA Find on LinkedIn ↗
-
Sakae Asanuma · DirectorCambridge, MA Find on LinkedIn ↗
-
Alon Lazarus · DirectorCambridge, MA Find on LinkedIn ↗
-
Dmitri Wiederschain · Executive OfficerCambridge, MA Find on LinkedIn ↗
-
Alexander Nolte · Executive OfficerCambridge, MA Find on LinkedIn ↗
View original on SEC EDGAR.